Medicinal Products

Tetraxim, suspenzija za injekciju u napunjenoj štrcaljki, cjepivo protiv difterije, tetanusa, hripavca (nestanično, komponentno) i poliomijelitisa (inaktivirano), adsorbirano

Name Tetraxim, suspenzija za injekciju u napunjenoj štrcaljki, cjepivo protiv difterije, tetanusa, hripavca (nestanično, komponentno) i poliomijelitisa (inaktivirano), adsorbirano
Marketing Authorisation Number HR-H-185201369
Active Substance toksoid difterije
toksoid tetanusa
toksoid hripavca
filamentozni hemaglutinin hripavca
poliovirus tip 1, soj Mahoney (inaktiviran)
poliovirus tip 2, soj MEF-1 (inaktiviran)
poliovirus tip 3, soj Saukett (inaktiviran)
Composition jedna doza (0,5 ml) sadrži: toksoid difterije (≥ 20 IU) (30 Lf), toksoid tetanusa (≥ 40 IU) (10 Lf), antigene bakterije Bordetella pertussis: toksoid hripavca (25 µg) i filamentozni hemaglutinin (25 µg), inaktivirane polioviruse tip 1 (29 D antigen jedinica), tip 2 (7 D antigen jedinica) i tip 3 (26 D antigen jedinica)
Pharmaceutical Form suspenzija za injekciju u napunjenoj štrcaljki
Manufacturer Sanofi Winthrop Industrie, Val de Reuil, Francuska
Sanofi Winthrop Industrie, Marcy L Etoile , Francuska
Sanofi-Aventis Zrt., Budimpešta XXII, Mađarska
Marketing Authorisation Holder Sanofi Winthrop Industrie, 82, avenue Raspail, Gentilly, Francuska
Marketing Authorisation Date 24.12.2024
MA Period of Validity unlimited
Classification Number UP/I-530-09/20-02/114
Registration Number 381-12-01/171-24-62
Prescription Medicinal product subject to medical prescription
Type of prescription Medicinal product subject to restricted medical prescription
Distribution Supply through pharmacies (community)
Advertising to general public not allowed
ATC Code J07CA02
Marketing status Marketed
Shortage status No shortage
SmPC download
PL download
Public Assessment Report download

Packaging

Back